United States · Platforms & data · Yahoo Finance

Mestag Therapeutics Appoints Philip Astley-Sparke and Victor Sandor, M.D.C.M., to its Board of Directors

Published by Yahoo Finance · United States 9 h ago

Mr. Astley-Sparke brings more than two decades of biotech leadership, having scaled several highly innovative transatlantic companies, including Replimune, uniQure and BioVex --…

Read the full article on Yahoo Finance Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading

MarketBeat

DNOW Inc. (NYSE:DNOW) Stock Rated "Moderate Buy" by Sell-Side Brokerages

MarketWatch

It’s a rough housing market, and Goldman Sachs expects it to get worse

The Motley Fool

President Donald Trump Claims, "We Don't Have Inflation, and Tariffs Don't Cause Inflation," but a New Report Strongly Disagrees

Seeking Alpha

U.S. to allow 'dark fleet' tankers to ship oil legally

Investing.com

France imposes curfews in parts of Paris, other cities after weekend of riots

CNBC